emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
Published 3 weeks ago • 4.2K plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
1:00
ipo alert | emcure pharma & bansal wire | ipo listing | n18s | cnbc tv18
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
0:45
new ipo: medi assist healthcare lists at 11% premium | n18v | cnbc tv18
-
13:24
domestic sales to export ratio will continue to be largely the same: emcure pharmaceuticals
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
3:06
akums drugs & pharma ipo opens today for subscription, price band fixed at ₹646-679/sh | cnbc tv18
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
4:06
emcure pharma ipo: all you need to know before investing
-
3:07
rahul shah's take on pharma sector & emcure pharma ipo |valuation concerns in market & bullish trend
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
1:33
emcure pharmaceuticals ipo: satish mehta expands on biotech brands and upcoming products
-
5:07
business news: sensex reaches 80,000, koo shuts down operations, emcure pharma ipo opens
-
20:11
emcure pharmaceuticals ipo: growth plans, existing profit & more | all you need to know
-
8:41
emcure pharma ipo oversubscribed; growth & expansion plans | samit mehta & vikas thapar | et now
-
8:00
emcure pharma ipo - opportunity or high valuation? | emcure pharma analysis |
-
8:30
emcure pharma ipo and bansal wire ipo - shocking | bank nifty and nifty analysis | 3/7/2024